Validation
Not a public sale stage
Used to validate workflows, reliability, usability and operating assumptions.
- Defined tester scope
- Structured feedback
- Controlled environments
- No false production claim
Pricing Direction
Price the product
after the product is proven.
TICS does not yet publish invented subscription numbers. Final commercial pricing depends on validated scope, onboarding, support, hosting, customer complexity and the capabilities included at launch. This page describes the intended commercial path without pretending those decisions are already final.
01 / Commercial Path
A staged model that matches actual product maturity.
Beta
Commercial terms defined per beta
For selected organizations prepared to test real workflows and contribute meaningful feedback.
- Early access
- Documented beta terms
- Direct feedback channel
- Defined implementation scope
SaaS
Pricing not yet finalized
Broader subscription availability after commercial readiness is proven.
- Production onboarding
- Defined support model
- Published feature scope
- Commercial service commitments
02 / What Affects Price
Operational software should not be priced
as though every implementation is identical.
Scope
Modules, workflows and operational responsibilities included.
Users & Sites
Number of users, teams, locations and organizational complexity.
Implementation
Configuration, migration, onboarding and rollout support required.
Customization
Special workflows, integrations, reporting or organization-specific requirements.
03 / Pricing Integrity
No artificial tiers just to make the page look finished.
Publishing arbitrary prices before TICS has completed controlled validation would create commitments unsupported by the current product and support model. When pricing is finalized, this page should show real packages, real inclusions and real commercial terms.
Every published package should state exactly what product capabilities are included.
Onboarding, support and hosting commitments must be defined before they are priced.
Commercial claims should follow validated product capability rather than marketing aspiration.